Transcat Inc 2026年季度报告

FORM 10-Q (Mark one)☑Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934For the quarterly period ended: June 27, 2026 or ☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to________Commission File Number: 000-03905 TRANSCAT, INC.(Exact name of registrant as specified in its charter) Ohio 16-0874418 (I.R.S. Employer Identification No.) (State or other jurisdiction ofincorporation or organization) 35 Vantage Point Drive, Rochester, New York 14624(Address of principal executive offices) (Zip Code) (585) 352-7777(Registrant's telephone number, including area code)Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.☑Yes No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).☑Yes No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smallerreporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☐ Large accelerated filer☑Non-accelerated filer☐Emerging growth company☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐Yes No☑ The number of shares of common stock, par value $0.50 per share, of the registrant outstanding as of July31, 2026 was 9,359,813. Page(s)PART I.FINANCIAL INFORMATIONItem 1.Condensed Consolidated Financial Statements (Unaudited):Condensed Consolidated Statements of Income for the Three Months Ended June 27, 2026 and June28, 20251Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended June 27,2026 and June 28, 20252Condensed Consolidated Balance Sheets as of June 27, 2026 and March 28, 20263Condensed Consolidated Statements of Cash Flows for the Three Months Ended June 27, 2026 andJune 28, 20254Condensed Consolidated Statements of Changes in Shareholders' Equity for the Three Months EndedJune 27, 2026 and June 28, 20256Notes to Condensed Consolidated Financial Statements7Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations17Item 3.Quantitative and Qualitative Disclosures about Market Risk26Item 4.Controls and Procedures27PART II.OTHER INFORMATIONItem 6.Exhibits28SIGNATURES29 PART I. FINANCIAL INFORMATION ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TRANSCAT, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME(Unaudited)(Amounts in Thousands, Except Per Share Amounts) TRANSCAT, INC.CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(Unaudited)(Dollars in Thousands) TRANSCAT, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)(Amounts in Thousands, Except Share and Per Share Amounts) TRANSCAT, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(Dollars in Thousands) TRANSCAT, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)(Unaudited)(Dollars in Thousands) TRANSCAT, INC.NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(Unaudited) NOTE 1– GENERAL Description of Business:Transcat, Inc. (“Transcat,” “we,” “us,” “our” or the “Company”) is a leading provider of accreditedcalibration services, cost control and optimization services, and distribution and rental of value-added professional grade handheld test,measurement and control instrumentation. The Company is focused on providing services and products to highly regulated industries,particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulatedbusinesses. Additional industries served include industrial manufacturing; energy and utilities, including oil and gas; chemicalmanufacturing; FAA-regulated businesses, including aerospace and defense and other industries that require accuracy in theirprocesses, confirmation of the capabilities of their equipment, and for which the risk of failure is very costly. Basis of Presentation:Transcat’s unaudited Condensed Consolidated Financial St